What is Skyclarys for Friedreich’s ataxia?
Category:
Treatment
Skyclarys (omaveloxolone) is the first therapy ever to be approved by the U.S. Food and Drug Administration (FDA) to treat Friedreich’s ataxia. Although Skyclarys is not a cure for the genetic disorder, the once-daily oral therapy has been proven to slow the progression of the disease in clinical trials.
About the Author
